Epidermal Growth Factor Receptor Inhibition for Keratinopathies
Epidermal Growth Factor Receptor Inhibition for Keratinopathies
Not yet recruiting · NCT06545695 · Registry updated 2026-08-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Epidermal Growth Factor Receptor Inhibition for Keratinopathies | Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ichthyosiform Erythroderma, Congenital, Infant, Newborn, Diseases, Keratoderma, Palmoplantar, Skin Abnormalities, Skin and Connective Tissue Diseases, ectodermal dysplasia syndrome, epidermolytic ichthyosis, hereditary disease, hereditary skin disorder, ichthyosis, keratosis, nail disorder, pachyonychia congenita, skin disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-08-03 | NCT06545695 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Northwestern University | 381 |
| Yale University | 458 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Dermatology, Northwestern University Feinberg School of Medicine | Chicago | United States | 1 |